J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406 - 24 Feb 2023
Best Paper Award
JPM Best Paper Award is granted annually to highlight publications of high quality, scientific significance, and extensive influence. The evaluation committee members choose 2 articles of exceptional quality that were published in the journal the year before the previous year and announce them online by the end of July.
The Prize:
– One research article and one review will be selected.
– Each winner will receive CHF 500, a certificate, and a free voucher for article processing fees valid for one year.
JPM Best Paper Award
Winner announcement: 31 July 2025
Eligibility and Requirements
– All papers published in the JPM will be eligible (both regular and Special Issue submissions).Selection Criteria
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
Past Winners
Year:
Winner
Predicting the Onset of Diabetes with Machine Learning Methods
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502 - 16 Oct 2023
Award Committee
Dr. Kenneth Pritzker
Chairman
Winner
Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions
J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279 - 14 Feb 2022
Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program
J. Pers. Med. 2022, 12(3), 421; https://doi.org/10.3390/jpm12030421 - 8 Mar 2022
Winner
Francine Durocher
1. Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1T 1C2, Canada
2. Cancer Research Center, CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada
Zhiqiang Kevin Lu
College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA
Winner
Molecular and Cellular Mechanisms Affected in ALS
Northern Ireland Center for Stratified/Personalised Medicine, Biomedical Sciences Research Institute, Ulster University, Derry-Londonderry BT47, UK
Postulated Adjuvant Therapeutic Strategies for COVID-19
Fagron. Lichtenauerlaan 182, 3062 Rotterdam, The Netherlands
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
CEINGE—Biotecnologie Avanzate s.c.a.r.l., 80131 Naples, Italy
Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Napoli, Italy
Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pasca
Award Committee
Prof. Dr. Richard E. Frye
Chairman
Autism Discovery and Treatment Foundation
Winner
S. Pamela K. Shiao
College of Nursing and Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
paper link: https://www.mdpi.com/2075-4426/8/1/10
